Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

DEPRECATED: Please see Data File entry for CSBC/PSON below with the rest of the portals.

This describes the 'Explore Data' table.

This is not a card, but an explore table.

File view driving this tableTable driving this: https://www.synapse.org/#!Synapse:syn21346411/tables/

Previously used a file view to drive Explore Datahttps://www.synapse.org/#!Synapse:syn9630847/tables/

...

portal namesynapse file view columnfacetconceptexampleGDC equivalentfaceted on GDCfacet on CSBCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portal
File NamenamenoThe name (or part of a name) of a file (of any type).
file_namenono





TitleTitleno










Speciesspeciesyes

none
yes





ThemeThemeyes
tumor-heterogeneitynone
yes





Data CategoryNAnoBroad categorization of the contents of the data file.
  • Transcriptome Profiling
data_categoryyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data TypeNAnoSpecific content type of the data file.
  • Exon Expression Quantification
  • Gene Expression Quantification
  • Isoform Expression Quantification
  • Splice Junction Quantification
data_typeyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

Data FormatfileFormatyesFormat of the data files.
  • CSV
  • HDF5
  • TSV
  • TXT
  • SRA XML
  • MAGE-TAB
  • SDRF
  • IDF
  • ADF
data_formatyesyes





AssayexperimentalStrategyyesThe sequencing strategy used to generate the data file.  REMOVE "sequencing" for CSBC.
  • RNA-Seq
  • Total RNA-Seq
experimental_strategyyesyes


CSBC will need to add values to those in GDC (which only cover sequencing)

file_sizeNAnoThe size of the data file (object) in bytes.
file_sizenono





md5sumNAnoThe 128-bit hash value expressed as a 32 digit hexadecimal number (in lower case) used as a file's digital fingerprint.
md5sumnono





PlatformNAno

platformyesyes





Disease Tumor TypetumorTypeyesThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




SiteNAnoThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case




EthnicityNAnoAn individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • hispanic or latino
  • not hispanic or latino
  • Unknown
  • not reported
  • not allowed to collect
demographic/ethnicityyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




GendersexyesText designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]
  • female
  • male
  • unknown
  • unspecified
  • not reported
demographic/genderyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




RaceNAnoAn arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • white
  • american indian or alaska native
  • black or african american
  • asian
  • native hawaiian or other pacific
demographic/raceyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic




TissuetissueyesThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyesyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




GrantcenterNameyes










Grant TypegrantTypeyes
U54 or U01








ProgramConsortiumconsortiumyes
CSBC or PSON








AgeNAno

diagnosis/age_at_diagnosisyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Primary DiagnosisNAnoText term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdominal desmoid
  • Abdominal fibromatosis
  • Achromic nevus
  • Acidophil adenocarcinoma
  • Acidophil adenoma
diagnosis/primary_diagnosisnonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




ProgressionNAnoYes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
  • yes
  • no
  • unknown
  • not reported
  • Not Allowed To Collect
diagnosis/progression_or_recurrencenonohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Vital StatusNAnoThe survival state of the person registered on the protocol.
  • alive
  • dead
  • lost to follow-up
  • unknown
  • not reported
diagnosis/vital_statusyes??https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis




Sample TypeNAnoText term to describe the source of a biospecimen used for a laboratory test.
  • Additional Metastatic
  • Additional - New Primary
  • Blood Derived Cancer - Bone Marrow, Post-treatment
  • Blood Derived Cancer - Peripheral Blood, Post-treatment
  • Blood Derived Normal
  • Bone Marrow Normal
  • Buccal Cell Normal
  • Cell Line Derived Xenograft Tissue
  • Cell Lines
sample/sample_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




Tissue TypeNAnoText term that represents a description of the kind of tissue collected with respect to disease status or proximity to tumor tissue.
  • Tumor
  • Normal
  • Abnormal
  • Peritumoral
  • Unknown
sample/tissue_typenoyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=sample




...